|
Independent
Family Doctors was one of the first organisations to offer
separate measles, mumps and rubella vaccinations to children
in the UK.
Since
2000 we have successfully vaccinated many children whose parents
had concerns regarding the safety of the MMR vaccination offered
to them by their NHS GPs.
It
has always been our policy to have doctor run clinics during
which parents have ample opportunity to discuss their concerns
and to address the needs of each child individually.
We
remain committed to sourcing all our vaccines from internationally
recognised manufacturers.
We
use Schwarz Strain vaccines (Rouvax made by Aventis Pasteur
MSD) to vaccinate against Measles. We
use Mumpsvax made by Merck & Co., USA (Jeryl Lynn Strain) to vaccinate against Mumps.
We
use Meruvax II made by Merck & Co., USA or Rudivax
made by Sanofi Pasteur MSD to vaccinate against
Rubella (Both contain the Wistar RA 27/3 strain).
Independent
Family Doctors has never used cheaper, Eastern European versions
of the Mumps vaccine used by some clinics in the UK. Our
vaccines are imported only from North America and Western
Europe; we never source our vaccines from the Third World.
Vaccines
are refrigerated at correct temperatures throughout transit
and are stored in our locked clinical refrigerators whose
temperatures are carefully monitored.
Prices
Measles
Vaccine consultation, supply and administration
£130
Mumps
Vaccine consultation, supply and administration
£130
Rubella
Vaccine consultation, supply and administration
£130
Chickenpox Vaccine consultation, supply and administration
£130
*booster doses for each vaccine may be required.
To book, call
0161-434-4731 or send Email to
info@singlejabs.co.uk
Vaccination
clinics are held every Tuesday morning.
Synopsis of research relating to MMR Vaccination
At
Manchester Independent Family Doctors, we understand the
difficulty encountered by parents in deciding whether or not
to have their child vaccinated with the MMR vaccine as
recommended by the department of health. The weight of
evidence supporting the safety of MMR is now rather large. The
evidence in support of a link between MMR and Autism or
Inflammatory Bowel Disease is very weak. We hope the research
summary below will help parents reach an informed decision on
choosing how their child will be vaccinated.
Research refuting
link between MMR and Autism/Inflammatory Bowel disease.
1.
Taylor et al, 1999. Lancet; 353: 2026-29. This was a UK
epidemiological study which looked at 498 autistic children.
It found that there was no difference in diagnosis of autism
whether the child was vaccinated before or after 18 months of
age or never vaccinated at all. It was also noted that there
was no observable increase in autism after the introduction of
MMR vaccination in 1988
2.
Kaye et al, 2001. BMJ; 322:82-85. This study examined 305
British children diagnosed with autism between 1988 (when MMR
vaccination was introduced) and 1999. It showed that the
numbers of children vaccinated with the MMR vaccine was
constant but that the numbers of children under 12yrs old
diagnosed with autism rose 7-fold during this period. It
concluded that if the MMR vaccine was responsible for this
increase in rates of autism, the increase in autism should
have flattened off within a few years of the vaccine being
introduced. As this was not the case, there was no evidence
for the MMR causing the increase in autism.
3.
Dales et al, 2001. JAMA (Journal of the American Medical
Association); 285. This study analysed rates of autism and MMR
uptake in California but found no correlation between the two.
4.
Peltola et al. 1998. Lancet; 351: 1327-28. This Finnish
research followed up children who developed bowel symptoms
lasting over 24hrs after having the MMR jab. It found that of
the 31 children it followed up, none developed autism in the 9
years following the administration of the MMR vaccine.
5.
Paediatric Infectious Disease Journal, 2000; 19: 1127-34. This
Finnish study looked at 1.8 million children who received the
MMR jab. It found that the risk of serious adverse events
attributable to the vaccine was only 3.2 per million vaccine
doses. It also noted that there was no increase in the rates
of autism or bowel disease amongst those vaccinated.
6.
Taylor et al. 2002. BMJ 324; 393-6. This research looked at
medical records and concluded that the proportion of children
with autism or bowel disorders has not changed since the MMR
vaccination programme was introduced.
7.
De Wilde et al. 2001. BJGP; 51:226-227. This research compared
the consultation rates at GP surgeries of autistic children
before and after MMR administration and found that there
was no difference in the number of visits to the GP by
these autistic children at 2 or 6 months after MMR
administration.
8.Miller et al. 2003. Archives of Disease in Childhood. This
research looked at hospital data relating to 436 children
admitted to hospital with serious bacterial infections between
April 1991 and March 1995. The researches looked to see if
children were more likely or not to have developed the
infections within 3 months of having the MMR jab. They
concluded that there was no increased risk of acquiring a
serious bacterial infection in the 3 months after
administration of the MMR jab. The researchers suggested that
this finding disproved the theory that giving the MMR vaccine
overloads the body's immune system.
9.
A Japanese study published in March 2005 looked at rates of
autism after the withdrawal of MMR vaccination in Japan. The
study found that rates of autism continued to rise.
Evidence
suggesting possible link between MMR Vaccine and autism.
1.
Wakefield et al, Lancet 1998; 351:637-641. This research
described 12 children referred to the Gastroenterology
department at the Royal Free Hospital. All twelve children had
intestinal and behavioural disorders when they were seen. All
twelve had apparently been developing normally prior to
parents noticing the symptoms. In 8 cases, the parents
believed the symptoms appeared shortly after having the MMR
vaccination. The researchers didn't claim to have proven a
link between the disorders and the administration of the MMR
jab. The sample size was too small to allow for accurate or
reliable conclusions to be made. One of the 13 authors of this
research suggested that children be given single jabs.
2.
Wakefield et al, Lancet 1999; 354: 949-950. This study showed
an apparent rise in autism in the UK and California coinciding
with the introduction of the MMR jab.
Evidence
suggesting MMR vaccination is a cause of Inflammatory Bowel
Disease.
1.
Kawashima, Wakefield et al, 2000. This research looked at
bowel tissue of patients with Inflammatory Bowel Disease and
found that measles virus particles were present in the bowel
tissue in 1 of 8 Crohns sufferers (wild measles virus
particles), 1 of 3 Ulcerative Colitis sufferers (vaccine
strain measles virus particles) and 3 of 9 autistic
enterocolitis sufferers.
2.
O'Leary et al, 2002. This research found that genetic material
of measles virus was present in bowel tissue samples from
children with Inflammatory Bowel Disease/Autism syndrome. No
distinction was made between wild measles strains or vaccine
measles strains.
Note: In March 2004, 10 co-authors of Dr Wakefield's original
paper published in the Lancet retracted their support for the
original findings.
Click here to see more research
on the MMR jab.
|
